Skip to main content
. Author manuscript; available in PMC: 2015 Nov 5.
Published in final edited form as: JAMA Psychiatry. 2014 Jul 1;71(7):797–805. doi: 10.1001/jamapsychiatry.2014.138

Table 1.

Demographic, Rating Scale, and Smoking-Related Variables for the Study Sample and Subgroups Randomly Assigned to Placebo or Nicotine Patch Treatment

Variable Study Sample
(N = 81)
Patch-Treated Subgroupa
Placebo
(n = 40)
Nicotine
(n = 41)
Age, mean (SD), y 40.7 (12.6) 42.7 (11.9) 38.6 (13.1)
Female, No. (%) 37 (45.7) 18 (45.0) 19 (46.3)
White, No. (%) 39 (48.1) 17 (42.5) 22 (53.7)
Education, mean (SD), y 14.5 (2.2) 14.3 (2.2) 14.8 (2.2)
Hamilton Anxiety Rating Scale score, mean (SD) 2.5 (2.8) 2.2 (2.1) 2.8 (3.4)
Hamilton Depression Rating Scale score, mean (SD) 2.5 (2.9) 2.3 (2.5) 2.7 (3.2)
FTND score, mean (SD) 4.4 (2.1) 4.6 (2.0) 4.3 (2.2)
Longest quit period, mean (SD), y 1.0 (1.6) 0.9 (1.5) 1.1 (1.7)
Cigarettes, No./d
    Pretreatment 15.4 (4.5) 15.4 (4.7) 15.3 (4.3)
    Posttreatment 6.8 (8.0)b 7.5 (7.1)b 6.3 (8.7)b
Change in cigarettes/d with treatment, mean (SD), % −57.8 (43.6) −52.7 (41.4) −62.7 (45.6)
Exhaled CO, mean (SD), ppm
    Pretreatment 13.8 (6.3) 14.5 (6.6) 13.1 (6.0)
    Posttreatment 8.7 (7.2)b 10.5 (7.8)b 6.9 (6.2)b
Change in exhaled CO with treatment, mean (SD), % −36.6 (42.7) −28.7 (38.6) −44.2 (45.5)
Smokers who quit with treatment, No. (%) 20 (24.7) 6 (15.0) 14 (34.1)c

Abbreviations: CO, carbon monoxide FTND, Fagerström Test for Nicotine Dependence.

a

No significant differences were found for baseline demographic or rating scale variables between smokers randomly assigned to the placebo vs nicotine patch treatment subgroups (t tests for continuous variables and Fisher exact tests for categorical variables).

b

P < .001 for within-group changes in cigarettes per day and exhaled CO from before to after treatment (paired t test).

c

P = .04 for difference between placebo and nicotine patch subgroups in percentage of quitters (Fisher exact test).